Introduction

The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector. This report presents leading products, developments, and market forecasts for each of these classes. Eighteen recently launched/late-stage pipeline products are discussed in detail.

Features and benefits

* Understand how recent events are affecting the performance of major products, and how companies are confronting competitive market changes.
* Compare the franchises of the leading companies in the cancer market, and understand how the market share of these companies will change.
* Assess key pipeline products by indication, ongoing trials, recent product launches, and key developments in R&D.
* Identify the challenges faced by leading players, and understand how recent events will impact the performance of leading products.
* Gain insights into the forecasts of the leading marketed and pipeline products through to 2016.

Highlights

The key factor for growth of the cancer therapy market is the expansion of target indications. Most of the blockbuster drugs were launched for a narrow indication, but later gained approval for a wider range of indications.
Regardless of indication, the key challenge in ensuring the commercial success of pipeline drugs is to ascertain their integration into current treatment regimens either in combination with existing therapies or by demonstrating significant superiority over current treatments.
Pricing risk remains the key investment concern in cancer. Moreover, the level of scrutiny by payers regarding the cost-effectiveness of cancer treatments has intensified in recent years.

Your key questions answered

* What will be the major growth indications and the accompanying growth drivers in the cancer market over the next 6 years?
* Which were the leading players in the cancer market in 2010?
* Which products will be the future growth drivers for the cancer health market?
* Which therapeutic categories are forecast to have the highest levels of commercial potential over the period 2010–16?
* Which companies are best positioned to succeed in the cancer market over the period 2010–16?

Executive Summary
Introduction
Legislation and regulation
Biodegradable packaging – technology, sectors and applications
Biodegradability and the packaging industry
Future outlook
Ian Barnett
Disclaimer
Introduction
Summary
What is biodegradable packaging?
Sustainability the main driver
Biodegradable packaging and composting
Increasing costs of hydrocarbons
Concerns over the price of biodegradable packaging
Lack of recyclability
Consumer attitudes to bioplastics
Consumer packaging market
The biodegradable plastics market
Legislation and regulation
Summary
Introduction
Packaging legislation in the European Union
Regulatory overview
Current EU regional picture
Bioplastics/biodegradable legislation in the EU
Certification and labeling
EU Directives
Lead Markets Initiative
Funding
Future outlook
Packaging legislation in the United States
US regulatory overview
US bioplastics/biodegradable legislation
Certification and labeling
US non-government organizations
The Bioplastics Recycling Consortium (BRC)
The Biodegradable Products Institute (BPI)
The Sustainable Packaging Coalition (SPC)
Walmart
Packaging regulations in Asia-Pacific
China
Japan
Singapore
Thailand
Indonesia
Global trends
Biodegradable drivers
Technology, sectors, and applications
Summary
Introduction
Technology
Biopolymers
Smart materials
Biodegradable barrier materials
Self-regulating, self-monitoring packaging
Sectors and applications for biodegradable packaging
Biodegradables are a vital target for investment
Bioplastics led by PLA
Oxo-biodegradable plastic – the new alternative
Recent commercial applications of biodegradable plastic packaging
Bioplastics market overview
Paper and board packaging
The biodegradability packaging industry
Summary
Major packaging companies with interests in biodegradable
NatureWorks
Cereplast
Cardia
Novamont
Manufacturers moving biodegradables into the mainstream
BASF
Biodegradable materials and brand names
Nature Flex
Ingeo
Mater-Bio
Nature Plus
Ecoflex
Retailer and manufacturer initiatives
Retailers
Manufacturers
Niche players
Future outlook
Summary
Introduction
Market outlook
Outlook for Suppliers
Who is driving the market?
Price drivers
Policy drivers
Consumer demand
Who is paying for the development and growth of biodegradable packaging?
Appendix
Scope
Methodology
Glossary/Abbreviations
Bibliography/References